Atlas Trials

Breast Cancer; HER2-positive; Metastatic

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Breast Cancer; HER2-positive; Metastatic

RecordFirmDate
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09) (NCT04784715)AstraZeneca2021-04-26

Track Breast Cancer; HER2-positive; Metastatic automatically

Every clearance here is in the API, with alerts when new ones post.